WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
“Company”) issued a press release announcing that its Board of
Directors has approved a third-quarter 2017 dividend of $0.13 per
share. The dividend will be paid on August 2, 2017, to
shareholders of record as of July 19, 2017.
overview of the business at the following investor conferences:
|
|
Bank of America Merrill Lynch 2017 Health Care Conference in
Las Vegas, Nevada on May 17, 2017 at 10:00 AM Pacific Daylight Time; |
|
|
2017 UBS Global Healthcare Conference in New York, New York
on May 23, 2017 at 2:00 PM Eastern Daylight Time; and |
|
|
Jefferies 2017 Global Healthcare Conference in New York, New
York on June 6, 2017 at 8:30 AM Eastern Daylight Time. |
hereto as Exhibit 99.1 and incorporated herein by reference.
conferences will be available through the Investors link at the
Company’s website, http://www.westpharma.com, and is also
attached hereto as Exhibit 99.2 and incorporated herein by
reference.
hereto) is being furnished to Item 7.01 and shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (“Exchange Act”), or otherwise subject
to the liabilities of that section, nor will it be incorporated
by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by
specific referencing in such filing.
|
(d)
|
Exhibits
|
|
|
|
Exhibit 99.1
|
West Pharmaceutical Services, Inc. Press Release, dated
May 15, 2017. |
|
|
Exhibit 99.2
|
West Pharmaceutical Services, Inc. Investor Presentation.
|
|
|
|
|
About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions. WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Recent Trading Information
WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) closed its last trading session down -0.37 at 95.90 with 363,125 shares trading hands.